2022-001410-20
Determining the clinical relevance of the interaction between enzalutamide and the opioid morphine and the DOAC edoxaban to improve rational pharmacological care of patients with prostate cancer
Radboud university medical center·EU Clinical Trials RegisterOngoing
Study focus
- Disease/Condition
- Prostate cancer
Sponsor & location
- Primary sponsor
- Radboud university medical center
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
Primary aim is to show that there is:
ICD-10 classifications
Malignant neoplasm of prostateHyperplasia of prostateDisorder of prostate, unspecifiedOther disorders of prostateCarcinoma in situ: Prostate
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2022-001410-20
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2022-001410-20 through Pure Global AI's free database. This phase not specified trial is sponsored by Radboud university medical center and is currently Ongoing. The study focuses on Prostate cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.